Axol Bioscience
Suite 3, The Science Village
Chesterford Research Park
Little Chesterford
Cambridgeshire
CB10 1XL
United Kingdom
Tel: 44-0-1223-751051
Website: http://www.axolbio.com/
24 articles about Axol Bioscience
-
Axol Bioscience Collaborates With StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
6/7/2023
Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.
-
At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside.
-
Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes to Help Improve Drug Discovery
6/7/2022
Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation.
-
Axol Bioscience Raises £3.2 million GBP (c. $4.2 million USD)
4/7/2022
Axol Bioscience Ltd. announced that it has raised £3.2 million GBP in the extension of its previous funding round, bringing the total raised to £7 million GBP.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Axol Bioscience and Censo Biotechnologies Announce Merger
3/17/2021
Merger accompanied by £3.8million ($5.3m USD) investment across shareholders, which will be used to fund recruitment and growth of the business
-
BioSpace Movers & Shakers, Jan. 15
1/15/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers. -
Axol Bioscience Strengthens Commercial Leadership Team With Key Appointments
1/13/2021
Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, announced the appointment of Ross Wheatcroft as the Global Strategic Accounts Manager.
-
BioSpace Global Roundup, Oct. 15
10/15/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells
10/13/2020
New services combine the Company’s iPSC-derived human cells and electrophysiological expertise with Axion Biosystems’ Maestro Pro MEA platform
-
BioSpace Movers & Shakers, Aug. 28
8/28/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Axol Bioscience appoints Liam Taylor as Chief Executive Officer
8/27/2020
Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced the appointment of Liam Taylor as CEO. Liam will guide the growth of the Company, and will focus on maximizing the potentia
-
Axol Bioscience Launches Human iPSC-derived Microglia
12/6/2018
Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
-
Axol Bioscience Opens US Office
9/20/2018
Axol, the rapidly growing specialist in human cell culture, is delighted to announce it has opened a new operational hub in the US.
-
Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes
7/23/2018
Axol Bioscience, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.
-
Specialist Stem Cell Biotech Axol Enhances Its Future Scientific And Commercial Endeavours
8/22/2017
-
Axol And Metrion Biosciences Announce Research Collaboration
7/26/2016
-
Axol Release: MESO-BRAIN Initiative Receives €3.3 Million To Replicate Brain’s Neural Networks Through 3D Nanoprinting
6/9/2016
-
Axol To Launch Novel iPSC-Derived Cells At ISSCR 2016
6/1/2016
-
Axol Launches iPSC-Derived Astrocyte Kits
5/12/2016